Mapping the GH Secretagogue Receptor in Both Pituitary and Hypothalamus at the Molecular Level
Molecular analysis confirmed GH secretagogue receptors (responding to GHRP-6 and MK-677) exist in both the pituitary and hypothalamus, using a distinct signaling pathway from GHRH.
Quick Facts
What This Study Found
GH secretagogue receptors are molecularly confirmed in both pituitary and hypothalamus, using a distinct signal transduction pathway from GHRH.
Key Numbers
How They Did This
Molecular biology analysis of GHS receptor expression in rat pituitary and hypothalamic tissues, characterizing binding and signaling properties.
Why This Research Matters
Confirming receptor expression at two sites explains the potency of GH secretagogues and validates the dual-mechanism model of their action.
The Bigger Picture
This molecular characterization completed the picture of how GH secretagogues work — dual-site action through a unique receptor and pathway.
What This Study Doesn't Tell Us
Rat tissue analysis; receptor characteristics may differ in humans. In vitro molecular analysis doesn't capture in vivo dynamics.
Questions This Raises
- ?Are hypothalamic and pituitary GHS receptors identical or distinct subtypes?
- ?Does GHS receptor density change with age or disease?
Trust & Context
- Key Stat:
- Dual-site receptor confirmed GHS receptors molecularly confirmed in both pituitary and hypothalamus, explaining GHRP potency
- Evidence Grade:
- Moderate molecular biology evidence providing definitive receptor characterization in two key tissues.
- Study Age:
- Published in 1997, contributing to the receptor characterization that preceded ghrelin's discovery.
- Original Title:
- Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.
- Published In:
- Molecular endocrinology (Baltimore, Md.), 11(4), 415-23 (1997)
- Authors:
- McKee, K K(5), Palyha, O C(2), Feighner, S D(6), Hreniuk, D L, Tan, C P, Phillips, M S, Smith, R G, Van der Ploeg, L H, Howard, A D
- Database ID:
- RPEP-00418
Evidence Hierarchy
Frequently Asked Questions
Why does it matter that the receptor is in two places?
Having receptors in both the hypothalamus and pituitary means GHRPs can stimulate GH release through two independent mechanisms simultaneously — like pressing two buttons at once. This is why GHRPs are so effective.
How is this different from GHRH?
GHRH acts primarily at the pituitary through its own receptor. GH secretagogues act at both the pituitary AND hypothalamus through a completely different receptor. When combined, they activate complementary pathways for a synergistic GH surge.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00418APA
McKee, K K; Palyha, O C; Feighner, S D; Hreniuk, D L; Tan, C P; Phillips, M S; Smith, R G; Van der Ploeg, L H; Howard, A D. (1997). Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.. Molecular endocrinology (Baltimore, Md.), 11(4), 415-23.
MLA
McKee, K K, et al. "Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.." Molecular endocrinology (Baltimore, 1997.
RethinkPeptides
RethinkPeptides Research Database. "Molecular analysis of rat pituitary and hypothalamic growth ..." RPEP-00418. Retrieved from https://rethinkpeptides.com/research/mckee-1997-molecular-analysis-of-rat
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.